Further Characterization of the Antiviral Transmembrane Protein MARCH8
Cells · 2024
DOI: 10.3390/cells13080698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Takuya Tada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan. Hauptthemen laut MEDLINE: HIV-1, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science, KAKENHI Grant-in-Aid for Scientific Research.
Abstract (Originalsprache)
The cellular transmembrane protein MARCH8 impedes the incorporation of various viral envelope glycoproteins, such as the HIV-1 envelope glycoprotein (Env) and vesicular stomatitis virus G-glycoprotein (VSV-G), into virions by downregulating them from the surface of virus-producing cells. This downregulation significantly reduces the efficiency of virus infection. In this study, we aimed to further characterize this host protein by investigating its species specificity and the domains responsible for its antiviral activity, as well as its ability to inhibit cell-to-cell HIV-1 infection. We found that the antiviral function of MARCH8 is well conserved in the rhesus macaque, mouse, and bovine versions. The RING-CH domains of these versions are functionally important for inhibiting HIV-1 Env and VSV-G-pseudovirus infection, whereas tyrosine motifs are crucial for the former only, consistent with findings in human MARCH8. Through analysis of chimeric proteins between MARCH8 and non-antiviral MARCH3, we determined that both the N-terminal and C-terminal cytoplasmic tails, as well as presumably the N-terminal transmembrane domain, of MARCH8 are critical for its antiviral activity. Notably, we found that MARCH8 is unable to block cell-to-cell HIV-1 infection, likely due to its insufficient downregulation of Env. These findings offer further insights into understanding the biology of this antiviral transmembrane protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
- Department of Microbiology, NYU Grossman School of Medicine, New York, NY 10016, USA.
- Key Laboratory of Environmental Stress and Chronic Disease Control and Prevention, Ministry of Education, China Medical University, Shenyang 110122, China.
- Department of Health Laboratory Technology, School of Public Health, China Medical University, Shenyang 110122, China.
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8555, Japan.
- Shenzhen Bay Laboratory, Institute of Chemical Biology, Shenzhen 518132, China.
ORCID-Profile: Takuya Tada, Yanzhao Zhang, Dechuan Kong, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research
- Japan Society for the Promotion of Science, KAKENHI Grant-in-Aid for Scientific Research
Zitieren
APA
Tada, T., Zhang, Y., Kong, D., Tanaka, M., Yao, W., Kameoka, M., Ueno, T., Fujita, H., & Tokunaga, K. (2024). Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells. https://doi.org/10.3390/cells13080698
Vancouver
Tada T, Zhang Y, Kong D, Tanaka M, Yao W, Kameoka M, et al. Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells. 2024. doi:10.3390/cells13080698
BibTeX
@article{Tada2024,
author = {Tada, Takuya and Zhang, Yanzhao and Kong, Dechuan and Tanaka, Michiko and Yao, Weitong and Kameoka, Masanori and Ueno, Takamasa and Fujita, Hideaki and Tokunaga, Kenzo},
title = {Further Characterization of the Antiviral Transmembrane Protein MARCH8},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13080698}
}
EUVIMED